Publikationen von 0000-0002-8392-9004
(ORCID: 0000-0002-8392-9004)
![]() | Eine Stufe nach oben |
Anzahl der Einträge: 9.
2021
Hau, Peter
, Frappaz, Didier, Hovey, Elizabeth, McCabe, Martin G.
, Pajtler, Kristian W., Wiestler, Benedikt
, Seidel, Clemens, Combs, Stephanie E., Dirven, Linda, Klein, Martin, Anazodo, Antoinette
, Hattingen, Elke
, Hofer, Silvia, Pfister, Stefan M.
, Zimmer, Claus, Kortmann, Rolf-Dieter, Sunyach, Marie-Pierre, Tanguy, Ronan, Effeney, Rachel, von Deimling, Andreas
, Sahm, Felix
, Rutkowski, Stefan, Berghoff, Anna S., Franceschi, Enrico, Pineda, Estela, Beier, Dagmar
, Peeters, Ellen, Gorlia, Thierry, Vanlancker, Maureen, Bromberg, Jacoline E. C., Gautier, Julien, Ziegler, David S.
, Preusser, Matthias, Wick, Wolfgang und Weller, Michael
(2021)
Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23.
Cancers 13 (14), S. 3451.
2019
Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke
, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert
, Weller, Johannes
, Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh
, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich
(2019)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal of Neuro-Oncology 144 (3), S. 501-509.
Volltext nicht vorhanden.
, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert
, Weller, Johannes
, Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh
, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich
(2019)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal of Neuro-Oncology 144 (3), S. 501-509.
Volltext nicht vorhanden.
Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter
, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes
, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
, Weller, Michael
, Fimmers, Rolf, Schmid, Matthias
, Hattingen, Elke
, Pietsch, Torsten, Coch, Christoph und Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes
, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
, Weller, Michael
, Fimmers, Rolf, Schmid, Matthias
, Hattingen, Elke
, Pietsch, Torsten, Coch, Christoph und Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
2018
Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke
, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter
, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Bähr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich und Glas, Martin
(2018)
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589.
Volltext nicht vorhanden.
, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter
, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Bähr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich und Glas, Martin
(2018)
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589.
Volltext nicht vorhanden.
2017
Keil, V. C., Warmuth-Metz, M., Reh, C., Enkirch, S. J., Reinert, C.
, Beier, D., Jones, D. T. W.
, Pietsch, T., Schild, H. H., Hattingen, E.
und Hau, P.
(2017)
Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.
American Journal of Neuroradiology 38 (10), S. 1892-1898.
Volltext nicht vorhanden.
, Beier, D., Jones, D. T. W.
, Pietsch, T., Schild, H. H., Hattingen, E.
und Hau, P.
(2017)
Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.
American Journal of Neuroradiology 38 (10), S. 1892-1898.
Volltext nicht vorhanden.
Beier, Dagmar, Proescholdt, Martin, Reinert, Christiane, Pietsch, Torsten, Jones, David T. W.
, Pfister, Stefan M.
, Hattingen, Elke
, Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E., Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter
(2017)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20 (3), S. 400-410.
Volltext nicht vorhanden.
, Pfister, Stefan M.
, Hattingen, Elke
, Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E., Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter
(2017)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20 (3), S. 400-410.
Volltext nicht vorhanden.
2016
Niyazi, Maximilian, Harter, Patrick N.
, Hattingen, Elke
, Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten und Mittelbronn, Michel
(2016)
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
Oncotarget 7 (3).
Volltext nicht vorhanden.
, Hattingen, Elke
, Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten und Mittelbronn, Michel
(2016)
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
Oncotarget 7 (3).
Volltext nicht vorhanden.
2015
Hutterer, M., Hattingen, E.
, Palm, C.
, Proescholdt, M. A. und Hau, P.
(2015)
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Neuro-Oncology 17 (6), S. 784-800.
Volltext nicht vorhanden.
, Palm, C.
, Proescholdt, M. A. und Hau, P.
(2015)
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Neuro-Oncology 17 (6), S. 784-800.
Volltext nicht vorhanden.
2014
Beck, Jürgen
, Gralla, Jan, Fung, Christian, Ulrich, Christian T., Schucht, Philippe, Fichtner, Jens, Andereggen, Lukas
, Gosau, Martin, Hattingen, Elke
, Gutbrod, Klemens
, Z'Graggen, Werner J., Reinert, Michael, Hüsler, Jürg, Ozdoba, Christoph und Raabe, Andreas
(2014)
Spinal cerebrospinal fluid leak as the cause of chronic subdural hematomas in nongeriatric patients.
Journal of Neurosurgery 121 (6), S. 1380-1387.
Volltext nicht vorhanden.
, Gralla, Jan, Fung, Christian, Ulrich, Christian T., Schucht, Philippe, Fichtner, Jens, Andereggen, Lukas
, Gosau, Martin, Hattingen, Elke
, Gutbrod, Klemens
, Z'Graggen, Werner J., Reinert, Michael, Hüsler, Jürg, Ozdoba, Christoph und Raabe, Andreas
(2014)
Spinal cerebrospinal fluid leak as the cause of chronic subdural hematomas in nongeriatric patients.
Journal of Neurosurgery 121 (6), S. 1380-1387.
Volltext nicht vorhanden.
